Longevity Startups

Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity. The company operates in the biotech and drug development sector.

7 investors

Everlab is a digital health platform offering personalized preventative medicine and longevity testing across Australia, combining bloodwork diagnostics, genetic testing, and specialist access with an app-based care coordination system guided by longevity-trained doctors.

7 investors

Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.

7 investors

Ezra offers advanced MRI-based full-body scans designed to screen for early signs of cancer and hundreds of other medical conditions. The service targets individuals seeking preventive health screening, with scans potentially eligible for HSA/FSA reimbursement.

7 investors

libify provides home care solutions for people in need of care and their relatives, including home emergency call systems with fall detection and GPS, care supply boxes of hygiene products, and certified online care courses. Based in Munich, it handles applications with statutory and private care insurance funds and offers a 24-hour German emergency call center.

7 investors

OneSkin develops skincare products based on its OS-01 Peptide, an ingredient the company says targets cellular senescence to address signs of skin aging. Founded by scientists, it positions its products within the longevity and skin-health consumer market.

7 investors

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer. It targets both companion animals (particularly dogs) and humans.

7 investors

Retirable offers holistic retirement planning through dedicated fiduciary financial advisors, providing customized investment plans, reliable monthly retirement income, high-yield cash savings, and $1M in identity theft protection. It serves individuals planning for and living in retirement.

7 investors

Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications. The company works on novel gene network therapies for challenging diseases.

7 investors

STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients. The company operates in the biotech sector, focused on advancing gene therapy for patients worldwide.

6 investors

Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration. The company focuses on patients with neurodegenerative conditions and applies genetics, neuroscience, and immunology to advance new treatments.

6 investors

Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability. The company uses human genetic data and clinical expertise to select drug targets in the obesity treatment landscape.

6 investors

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.

6 investors

Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. The therapies use modified blood stem cells to restore function of affected genes and offer potential cures rather than symptom management.

6 investors

Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging. The company aims to reintroduce beneficial worm-derived components without live worms.

6 investors

Isaac Health provides virtual, interdisciplinary care for people experiencing memory and thinking changes, staffed by board-certified neurologists, geriatric specialists, neuropsychologists, speech-language pathologists, and care navigators. It offers nationwide telehealth services in the US focused on diagnosing, treating, and supporting patients with cognitive conditions.

6 investors

Jukebox Health helps older adults and people with disabilities live safely at home by combining licensed occupational therapist evaluations with a network of vetted installers to identify home safety risks and manage product ordering, delivery, and installation. It serves aging-at-home and disability populations in the home health and safety space.

6 investors

Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.

6 investors

LifeQ develops a health technology platform focused on longevity, biological age optimization, and performance metrics for individual health monitoring and management.

6 investors

NiaHealth offers precision longevity health assessments for Canadians, measuring biomarkers and providing personalized health plans delivered by licensed Nurse Practitioners. Its clinical team combines evidence-based longevity research with coaching to translate test results into actionable recommendations, integrating with members' family doctors where needed.

6 investors

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations. Its lead program is rezatapopt, a reactivator of the p53 Y220C mutation in clinical trials.

6 investors

Qida provides in-home care services for elderly and dependent people in Spain, matching families with professional caregivers on a flexible basis (from one hour a week to live-in 24/7 care) with ongoing supervision by psychologists or social workers. It also offers complementary services such as physiotherapy, help contracting caregivers, and assistance managing public dependency-law subsidies.

6 investors

Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.

6 investors

RubyWell connects family caregivers of homebound older adults with Medicare Advantage plans and home health agencies, offering care navigation support, training, and monthly stipends through a structured study program. Its technology helps caregivers identify early health signals and access Medicare-covered home health services to reduce avoidable hospitalizations for chronically ill patients in the US.

6 investors